Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[ancestry category]	Characteristics[developmental stage]	Characteristics[sex]	Characteristics[disease]	Characteristics[phenotype]	Characteristics[individual]	Characteristics[enrichment process]	Material Type	assay name	Technology Type	comment[label]	comment[data file]	comment[file uri]	comment[fractionation method]	comment[technical replicate]	comment[fraction identifier]	comment[cleavage agent details]	comment[cleavage agent details]	comment[ms2 mass analyzer]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[phenotype]	factor value[enrichment process]
Sample 1	Homo sapiens	breast	50Y	HCC38	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 1	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C1.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	breast	50Y	HCC38	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 2	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C1_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C1_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	breast	50Y	HCC38	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 3	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C1b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C1b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	breast	50Y	HCC38	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 4	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C1b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C1b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 5	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 6	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 7	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 8	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 9	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3c.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3c.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	breast	51Y	MDA-MB-231	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 10	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C3c_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C3c_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 11	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 12	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 13	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 14	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 15	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4c.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4c.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	breast	74Y	Hs578T	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 16	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C4c_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C4c_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 17	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 18	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 19	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 20	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 21	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5c.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5c.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	breast	51Y	MDA-MB-468	Epithelial	Black	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 22	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C5c_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C5c_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	breast	38Y	MDA-MB-415	Epithelial	not available	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 23	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C6.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	breast	38Y	MDA-MB-415	Epithelial	not available	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 24	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C6_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C6_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	breast	38Y	MDA-MB-415	Epithelial	not available	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 25	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C6b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C6b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	breast	38Y	MDA-MB-415	Epithelial	not available	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 26	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C6b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C6b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	breast	52Y	HCC1143	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 27	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C7.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	breast	52Y	HCC1143	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 28	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C7_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C7_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 15	Homo sapiens	breast	52Y	HCC1143	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 29	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C7b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C7b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 15	Homo sapiens	breast	52Y	HCC1143	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 30	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C7b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C7b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 16	Homo sapiens	breast	44Y	MDA-MB-157	Epithelial	Black	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 31	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C8.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 16	Homo sapiens	breast	44Y	MDA-MB-157	Epithelial	Black	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 32	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C8_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C8_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 17	Homo sapiens	breast	44Y	MDA-MB-157	Epithelial	Black	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 33	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C8b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C8b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 17	Homo sapiens	breast	44Y	MDA-MB-157	Epithelial	Black	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 34	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C8b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C8b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 18	Homo sapiens	breast	23Y	BT483	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 35	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C9.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 18	Homo sapiens	breast	23Y	BT483	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 36	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C9_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C9_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 19	Homo sapiens	breast	23Y	BT483	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 37	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C9b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C9b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 19	Homo sapiens	breast	23Y	BT483	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 38	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C9b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C9b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 20	Homo sapiens	breast	23Y	HCC1937	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 39	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C10.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 20	Homo sapiens	breast	23Y	HCC1937	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	agressive	not applicable	enrichment of phosphorylated Protein	cell line	run 40	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C10_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C10_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	agressive	enrichment of phosphorylated Protein
Sample 21	Homo sapiens	breast	23Y	HCC1937	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 41	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C10b.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C10b.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 21	Homo sapiens	breast	23Y	HCC1937	Epithelial	Caucasian	adult	female	Triple-negative breast cancer	indolent	not applicable	enrichment of phosphorylated Protein	cell line	run 42	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20131217_OR8_RP_HP_C10b_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20131217_OR8_RP_HP_C10b_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 22	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	indolent	4020303	enrichment of phosphorylated Protein	Biopsy	run 43	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B10A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B10A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 23	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	indolent	4020361	enrichment of phosphorylated Protein	Biopsy	run 44	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B12A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B12A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	indolent	enrichment of phosphorylated Protein
Sample 24	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020351	enrichment of phosphorylated Protein	Biopsy	run 45	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B13A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B13A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 25	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020326	enrichment of phosphorylated Protein	Biopsy	run 46	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B14A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B14A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 26	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020194	enrichment of phosphorylated Protein	Biopsy	run 47	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B15A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B15A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 27	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020171	enrichment of phosphorylated Protein	Biopsy	run 48	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B16A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B16A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 28	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	46090827	enrichment of phosphorylated Protein	Biopsy	run 49	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B17A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B17A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 29	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	46090821	enrichment of phosphorylated Protein	Biopsy	run 50	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B18A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B18A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 30	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090817	enrichment of phosphorylated Protein	Biopsy	run 51	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B19A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B19A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 31	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030239	enrichment of phosphorylated Protein	Biopsy	run 52	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B1B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B1B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 32	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110113	enrichment of phosphorylated Protein	Biopsy	run 53	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B20A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B20A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 33	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110112	enrichment of phosphorylated Protein	Biopsy	run 54	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B21A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B21A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 34	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030181	enrichment of phosphorylated Protein	Biopsy	run 55	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B2A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B2A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 35	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030181	enrichment of phosphorylated Protein	Biopsy	run 56	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B2B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B2B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 36	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11010247	enrichment of phosphorylated Protein	Biopsy	run 57	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B35A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B35A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 37	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11010310	enrichment of phosphorylated Protein	Biopsy	run 58	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B36A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B36A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 38	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11040041	enrichment of phosphorylated Protein	Biopsy	run 59	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B37A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B37A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 39	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11050016	enrichment of phosphorylated Protein	Biopsy	run 60	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B38A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B38A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 40	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11050061	enrichment of phosphorylated Protein	Biopsy	run 61	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B39A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B39A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 41	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030124	enrichment of phosphorylated Protein	Biopsy	run 62	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B3A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B3A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 42	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030124	enrichment of phosphorylated Protein	Biopsy	run 63	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B3B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B3B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 43	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11060331	enrichment of phosphorylated Protein	Biopsy	run 64	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B42A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B42A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 44	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11020374	enrichment of phosphorylated Protein	Biopsy	run 65	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B43A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B43A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 45	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020534	enrichment of phosphorylated Protein	Biopsy	run 66	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B4A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B4A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 46	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020534	enrichment of phosphorylated Protein	Biopsy	run 67	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B4B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B4B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 47	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020467	enrichment of phosphorylated Protein	Biopsy	run 68	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B5A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B5A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 48	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020467	enrichment of phosphorylated Protein	Biopsy	run 69	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B5B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B5B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 49	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020373	enrichment of phosphorylated Protein	Biopsy	run 70	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B6A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B6A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 50	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020373	enrichment of phosphorylated Protein	Biopsy	run 71	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B6B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B6B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 51	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 72	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B7A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B7A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 52	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 73	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B7B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B7B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 53	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020328	enrichment of phosphorylated Protein	Biopsy	run 74	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B8A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B8A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 54	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020328	enrichment of phosphorylated Protein	Biopsy	run 75	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B8B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B8B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 55	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020325	enrichment of phosphorylated Protein	Biopsy	run 76	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140108_OR8_RP_HP_B9A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140108_OR8_RP_HP_B9A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 22	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020303	enrichment of phosphorylated Protein	Biopsy	run 77	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B10A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B10A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 56	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020303	enrichment of phosphorylated Protein	Biopsy	run 78	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B10B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B10B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 56	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020303	enrichment of phosphorylated Protein	Biopsy	run 79	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B10B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B10B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 23	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020361	enrichment of phosphorylated Protein	Biopsy	run 80	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B12A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B12A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 57	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020351	enrichment of phosphorylated Protein	Biopsy	run 81	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B13B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B13B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 57	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020351	enrichment of phosphorylated Protein	Biopsy	run 82	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B13B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B13B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 25	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020326	enrichment of phosphorylated Protein	Biopsy	run 83	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B14A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B14A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 58	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020326	enrichment of phosphorylated Protein	Biopsy	run 84	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B14B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B14B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 58	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020326	enrichment of phosphorylated Protein	Biopsy	run 85	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B14B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B14B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 26	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020194	enrichment of phosphorylated Protein	Biopsy	run 86	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B15A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B15A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 59	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020194	enrichment of phosphorylated Protein	Biopsy	run 87	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B15B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B15B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 59	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020194	enrichment of phosphorylated Protein	Biopsy	run 88	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B15B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B15B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 27	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020171	enrichment of phosphorylated Protein	Biopsy	run 89	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B16A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B16A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 60	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020171	enrichment of phosphorylated Protein	Biopsy	run 90	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B16B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B16B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 28	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	46090827	enrichment of phosphorylated Protein	Biopsy	run 91	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B17A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B17A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 61	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	46090827	enrichment of phosphorylated Protein	Biopsy	run 92	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B17B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B17B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 61	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090827	enrichment of phosphorylated Protein	Biopsy	run 93	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B17B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B17B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 29	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090821	enrichment of phosphorylated Protein	Biopsy	run 94	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B18A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B18A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 62	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090821	enrichment of phosphorylated Protein	Biopsy	run 95	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B18B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B18B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 62	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090821	enrichment of phosphorylated Protein	Biopsy	run 96	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B18B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B18B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 30	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090817	enrichment of phosphorylated Protein	Biopsy	run 97	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B19A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B19A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 63	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090817	enrichment of phosphorylated Protein	Biopsy	run 98	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B19C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B19C.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 63	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	46090817	enrichment of phosphorylated Protein	Biopsy	run 99	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B19C_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B19C_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 31	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030239	enrichment of phosphorylated Protein	Biopsy	run 100	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B1B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B1B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 32	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110113	enrichment of phosphorylated Protein	Biopsy	run 101	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B20A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B20A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 64	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110113	enrichment of phosphorylated Protein	Biopsy	run 102	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B20C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B20C.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 64	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110113	enrichment of phosphorylated Protein	Biopsy	run 103	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B20C_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B20C_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 33	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110112	enrichment of phosphorylated Protein	Biopsy	run 104	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B21A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B21A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 65	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110112	enrichment of phosphorylated Protein	Biopsy	run 105	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B21B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B21B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 65	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	110112	enrichment of phosphorylated Protein	Biopsy	run 106	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B21B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B21B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 34	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030181	enrichment of phosphorylated Protein	Biopsy	run 107	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B2A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B2A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 35	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030181	enrichment of phosphorylated Protein	Biopsy	run 108	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B2B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B2B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 36	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11010247	enrichment of phosphorylated Protein	Biopsy	run 109	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B35A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B35A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 37	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11010310	enrichment of phosphorylated Protein	Biopsy	run 110	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B36A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B36A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 38	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11040041	enrichment of phosphorylated Protein	Biopsy	run 111	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B37A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B37A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 39	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11050016	enrichment of phosphorylated Protein	Biopsy	run 112	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B38A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B38A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 40	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11050061	enrichment of phosphorylated Protein	Biopsy	run 113	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B39A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B39A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 41	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030124	enrichment of phosphorylated Protein	Biopsy	run 114	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B3A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B3A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 42	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4030124	enrichment of phosphorylated Protein	Biopsy	run 115	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B3B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B3B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 43	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11060331	enrichment of phosphorylated Protein	Biopsy	run 116	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B42A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B42A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 44	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11020374	enrichment of phosphorylated Protein	Biopsy	run 117	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B43A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B43A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 66	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	11020374	enrichment of phosphorylated Protein	Biopsy	run 118	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B43B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B43B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 66	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11020374	enrichment of phosphorylated Protein	Biopsy	run 119	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B43B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B43B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 67	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11060260	enrichment of phosphorylated Protein	Biopsy	run 120	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B44A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B44A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 67	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11060260	enrichment of phosphorylated Protein	Biopsy	run 121	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B44A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B44A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 68	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11070168	enrichment of phosphorylated Protein	Biopsy	run 122	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B45A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B45A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 68	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11070168	enrichment of phosphorylated Protein	Biopsy	run 123	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B45A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B45A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 69	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11080169	enrichment of phosphorylated Protein	Biopsy	run 124	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B47A.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B47A.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 69	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	11080169	enrichment of phosphorylated Protein	Biopsy	run 125	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B47A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B47A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 45	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020534	enrichment of phosphorylated Protein	Biopsy	run 126	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B4A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B4A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 46	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020534	enrichment of phosphorylated Protein	Biopsy	run 127	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B4B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B4B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 47	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020467	enrichment of phosphorylated Protein	Biopsy	run 128	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B5A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B5A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 48	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020467	enrichment of phosphorylated Protein	Biopsy	run 129	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B5B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B5B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 49	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020373	enrichment of phosphorylated Protein	Biopsy	run 130	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B6A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B6A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 50	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020373	enrichment of phosphorylated Protein	Biopsy	run 131	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B6B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B6B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 51	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 132	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B7A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B7A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 52	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 133	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B7B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B7B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 70	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 134	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B7C.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B7C.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 70	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020348	enrichment of phosphorylated Protein	Biopsy	run 135	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B7C_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B7C_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 53	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020328	enrichment of phosphorylated Protein	Biopsy	run 136	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B8A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B8A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 54	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020328	enrichment of phosphorylated Protein	Biopsy	run 137	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B8B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B8B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 55	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020325	enrichment of phosphorylated Protein	Biopsy	run 138	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B9A_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B9A_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 71	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	no relapse	4020325	enrichment of phosphorylated Protein	Biopsy	run 139	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B9B.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B9B.raw	not available	1	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	no relapse	enrichment of phosphorylated Protein
Sample 71	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020325	enrichment of phosphorylated Protein	Biopsy	run 140	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140113_OR8_RP_HP_B9B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140113_OR8_RP_HP_B9B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
Sample 60	Homo sapiens	breast	not available	not applicable	not applicable	not available	not available	not available	Triple-negative breast cancer	relapse	4020171	enrichment of phosphorylated Protein	Biopsy	run 141	proteomic profiling by mass spectrometry	AC=MS:1002038;NT=label free sample	20140117_OR8_RP_HP_B16B_rr.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/07/PXD008012/20140117_OR8_RP_HP_B16B_rr.raw	not available	2	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C;AC=MS:1001309	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Elite;AC=MS:1001910	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variabl	NT=Phospho;MT=variable;TA=S,T,Y;AC=UNIMOD:21	AC=MS:1000133;NT=CID	35% NCE	20 ppm	not available	relapse	enrichment of phosphorylated Protein
